Testing effectiveness (Phase 2)Study completedNCT01407471
What this trial is testing
Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy
Who this might be right for
Cutaneous Atrophy Due to Corticosteroids
Assistance Publique - Hôpitaux de Paris 26